➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: September 23, 2020

DrugPatentWatch Database Preview


➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for Ethosuximide

A generic version of ETHOSUXIMIDE was approved as ethosuximide by PHARM ASSOC on November 22nd, 2000.

  Start Trial

Drug patent expirations by year for ETHOSUXIMIDE
Drug Prices for ETHOSUXIMIDE

See drug prices for ETHOSUXIMIDE

Recent Clinical Trials for ETHOSUXIMIDE

Identify potential brand extensions & 505(b)(2) entrants

Johns Hopkins UniversityPhase 3
Tanta UniversityPhase 3
Zhejiang UniversityEarly Phase 1

See all ETHOSUXIMIDE clinical trials

Pharmacology for ETHOSUXIMIDE
Medical Subject Heading (MeSH) Categories for ETHOSUXIMIDE

US Patents and Regulatory Information for ETHOSUXIMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn ETHOSUXIMIDE ethosuximide CAPSULE;ORAL 040686-001 May 28, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Pharm Assoc ETHOSUXIMIDE ethosuximide SYRUP;ORAL 040253-001 Nov 22, 2000 AA RX No No   Start Trial   Start Trial   Start Trial
Puracap Pharm Llc ETHOSUXIMIDE ethosuximide CAPSULE;ORAL 210654-001 Mar 16, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.